Milk Thistle (Silymarin) vs NMN (Nicotinamide Mononucleotide)

Mechanism

Silymarin is a complex of flavonolignans (silybin A, silybin B, silychristin, silydianin, isosilybin) with silybin being the most active. Hepatoprotective mechanisms: stabilizes hepatocyte cell membranes by altering outer lipid layer composition (preventing toxin penetration), stimulates ribosomal RNA polymerase I (accelerating hepatocyte protein synthesis and regeneration), inhibits NF-kB and TNF-alpha (anti-inflammatory), scavenges free radicals (both ROS and RNS), promotes glutathione synthesis (increases intracellular GSH by 35%), and inhibits hepatic stellate cell activation (anti-fibrotic). Silybin also activates AMPK and enhances bile flow.

Standard Dosing

200-400mg silymarin daily (standardized to 70-80% silymarin)

Timing

With meals. Split doses for higher amounts. Phytosome form can be taken without food.

Cycle Duration

Cycle 8-12 weeks for liver support; ongoing at low dose for maintenance

Side Effects

• GI discomfort (mild laxative effect)
• Headache
• Allergic reactions (Asteraceae allergy)
• Rare: anaphylaxis

Contraindications

• Allergy to Asteraceae/Compositae family plants (ragweed, daisies, marigolds)
• Caution with hormone-sensitive conditions (weak estrogenic activity reported for some silymarin components)

Best Stacking Partners

Mechanism

NMN is a direct biosynthetic precursor to NAD+ via the salvage pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT). Elevated NAD+ activates sirtuins (SIRT1-7), PARP DNA repair enzymes, and CD38/CD157 signaling. SIRT1 activation deacetylates PGC-1alpha (mitochondrial biogenesis), FOXO transcription factors (stress resistance), and NF-kB (anti-inflammatory). NMN also enters cells via the Slc12a8 transporter, recently identified in the gut.

Standard Dosing

500-1000mg daily

Timing

Morning on empty stomach. Sublingual absorption bypasses first-pass metabolism.

Cycle Duration

ongoing

Side Effects

• Mild GI discomfort
• Flushing (rare, unlike niacin)
• Mild headache during initial use

Contraindications

• Active cancer (theoretical concern: NAD+ may fuel rapidly dividing cells)
• Pregnancy/lactation (insufficient data)
• Theoretical concern in active cancer (NAD+ fuels all rapidly dividing cells)

Best Stacking Partners